Font Size: a A A

Safflower Yellow Injection In The Treatment Of Angina Pectoris (heart Blood Stasis Syndrome) Clinical Studies

Posted on:2008-09-27Degree:MasterType:Thesis
Country:ChinaCandidate:L L GaoFull Text:PDF
GTID:2204360215973524Subject:Chinese medical science
Abstract/Summary:PDF Full Text Request
The attack rate of coronary heart disease (CHD) is high. It is a serious cardiovascular system diseases threatening people's health . In recent years, the experiments and clinical study on treatment of CHD with activating blood and transforming stasis method have acquired great advance. The article have refered to literatures for the experiments and clinical study on treatment of CHD with activating blood and transforming stasis method.I hope it is a theoretical direction for making a diagnosis and give treatment to CHD and cognitioning the activating blood and transforming stasis method. On the basis of these studies I applied a series of clinical observation. Objective: To evaluate the efficacy and security of Safflor yellow for treating stable anginapectoris with blood stasis in heart syndrome of TCM . MethodsrThe 68 patients of stable anginapectoris with blood stasis in heart syndrome of TCM were randomized into treatment group(34) and control group (34) according to randomized digital form. The patients of treatment group were given SY 0. 12g, iv, each day; the control group was given "xiangdan" injection 10mL, iv, each day. The treatment duration was two weeks. The patients were specially asked not to accept any medicine for CHD but glonoine during the trial. Results:After treatment, scores of angina pectoris attack frequency, chest pain-degree, lasting time, being taken show significan decrease compared with that before treatment in both group(P<0. 05). Total curative effect rate of angina pectoris is 85.29%; TCM syndrome score, chest pain, chest stuff and palpitation significantly decrease compared with that before treatment(P<0. 05). Total curative effect rate of TCM syndrome is 94.12%.Comprehensive valuation the curative effect of CHD, the total curative effect rate of diseases is 85.29%. SY can significantly improve coagulative functional and can decrease significantly the dose of glonoin (P<0.05) .Score of lasting time,chest pain - degree,relieving chest pain,chest stuff and palpitationand ect in the treatment group is lower than that in the control group(P<0. 05). And the total curative effect rate of TCM syndrome,angina pectoris and the total curative effect rate of diseases is higher than that in the control group(P<0.05). This drug had not obvious effects on improving Common ECG and Treadmill exercise test(P>0.05). The total curative effect rate of ECG is 44.12%. There is no significant difference between the treatment group and the control group on ECG and Treadmill exercise test (P>0.05). Safety items of the both group show no obvious difference before and after treatment. There are no significant adverse effects in both groups during the treatment. Conclusion: SY is safe and effective for stable angina pectoris with syndrome of blood stasis in heart syndrome.
Keywords/Search Tags:Safflor yellow, Coronary heart disease, Stableangina pectoris, Blood stasis in heart syndrome
PDF Full Text Request
Related items
Safflower Yellow Pigment Treatment Of Angina Pectoris (heart Blood Stasis Syndrome) Clinical Studies
A Clinical Trial To Evaluate The Effect Of Safflower Yellow Injection In Treating Coronary Heart Disease Angina Pectoris(Heart Blood Stasis Syndrome)
Bees Yellow Dropping Pill Treatment Of Coronary Heart Disease Angina Pectoris (Qi Deficiency Blood Stasis Syndrome) Clinical Research
Clinical Research On The Injection Uses Safflower Yellow/The Safflower Pigment Inoculation Fluid Treats Coronary Disease Angina Pectoris (Type Of Heart Blood Stasis)
Study On CircRNA Mechanism Of Huoxue Huayu Recipe In The Treatment Of Stable Angina Pectoris Of Coronary Heart Disease With Heart And Blood Stasis Syndrome
Clinical Observation Of Liqi Huoxue Dripping Pills In The Treatment Of Coronary Heart Disease With Stable Angina Pectoris(Heart Yang Deficiency And Heart Blood Stasis Syndrome)
Pharmacodynamics Interpretation And Dimensional Annotation To Dynamic Change Of Blood Stasis Syndrome Of Angina Pectoris Of Coronary Heart Disease
Tailixin Capsule For Heart Blood Stasis Syndrome Of Chest Bi (angina Pectoris Of Coranary Heart Disease): A Randomized Double-blind Controlled Clinical Trial
Tailixin Capsule For Heart Blood Stasis Syndrome Of Chest Bi (Angina Pectoris Of Coranary Heart Disease): A Randomized Double-blind Controlled Clinical Trial
10 Tailixin Capsule For Angina Pectoris Of Coranary Heart Disease (Heart Blood Stasis Syndrome): Phase Ⅱ Multi-central Clinical Trials